The Business Research Company’s Polycystic Ovarian Syndrome Treatment Global Market Report 2021: COVID-19 Growth And Change To 2030
LONDON, GREATER LONDON, UK, July 16, 2021 /EINPresswire.com/ — Laparoscopic ovarian drilling is a major trend driving the growth of the polycystic ovarian syndrome treatment market. Laparoscopic ovarian drilling is a surgical treatment performed by the doctors in critical conditions that can cause ovulation in women with polycystic ovary syndrome (PCOS). Ovarian drilling is often used by women with PCOS who often do not ovulate despite having attempted weight loss and use of fertility drugs. According to the study published in 2019 by the Department of Gynecology and Obstetrics in major hospitals in France, after laparoscopic drilling, 47.4% (137 patients) had pregnancy and 51.8% (71 patients) of these were spontaneous. 16.6% (48 patients) women had at least two pregnancies after drilling and 56.3% (27 patients) of these were spontaneous. 33 women received second drillings. Of these, 57.6% (19 patients) achieved at least one pregnancy, within this 52.6% (10 patients) were spontaneous.
The global polycystic ovarian syndrome treatment market size is expected to grow from $3.67 billion in 2020 to $3.96 billion in 2021 at a compound annual growth rate (CAGR) of 7.9%. The growth is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The polycystic ovarian syndrome treatment market is expected to reach $4.76 billion in 2025 at a CAGR of 5%.
Read More On The Global Polycystic Ovarian Syndrome Treatment Market Report:
Major players in the PCOS treatment market are Bristol-Myer Squibb Company, Bayer AG, Pfizer Inc., Merck KGaA, Sanofi, AstraZeneca, Novartis AG, Teva Pharmaceutical Industries Limited, Abbott and Addex Therapeutics Ltd.
In July 2019, Eurolife Healthcare Pvt. Ltd, a Mumbai based company, manufactures and distributes an exclusive portfolio of healthcare formulations, intravenous infusions, ophthalmic, sterilized water for injections, nebules, tablets, capsules, ointment & creams, acquired Teva Pharmaceutical Industries Ltd. for an undisclosed amount. Teva Pharmaceutical Industries Ltd., a multinational pharmaceutical company, develops, manufactures, and markets generic and branded human pharmaceuticals as well as active pharmaceutical ingredients. This acquisition helped the company to tap and service its European and the US markets for intravenous infusions in a better way.
TBRC’s polycystic ovary syndrome (PCOS) treatment market report is segmented by drug type into oral contraceptives, ornithine decarboxylase inhibitors, insulin-sensitizing agents, anti-depressants, diuretics, aromatase inhibitors. The polycystic ovarian syndrome treatment market is also segmented by surgery type into ovarian wedge resection and laparoscopic ovarian drilling, and by end user into hospitals and clinics, ambulatory surgical centers, diagnostic centers, gynecology centers, feminist health centers.
Polycystic Ovarian Syndrome Treatment Global Market Report 2021: COVID-19 Growth And Change To 2030 is one of a series of new reports from The Business Research Company that provides polycystic ovarian syndrome treatment market overview, forecast polycystic ovarian syndrome treatment market size and growth for the whole market, polycystic ovarian syndrome treatment market segments, and geographies, polycystic ovarian syndrome treatment market trends, polycystic ovarian syndrome treatment market drivers, restraints, leading competitors’ revenues, profiles, and market shares.
Request For A Sample Of The Global Polycystic Ovarian Syndrome Treatment Market Report:
Here Is A List Of Similar Reports By The Business Research Company:
Gynecology Medical Lasers Global Market Report 2021: COVID-19 Growth And Change To 2030
Fertility Treatments Global Market Report 2021: COVID-19 Growth And Change To 2030
Fertility Services Global Market Report 2021: COVID-19 Growth And Change to 2030
IVF Services Global Market Report 2021: COVID-19 Growth And Change to 2030
Interested to know more about The Business Research Company?
Read more about us at https://www.thebusinessresearchcompany.com/about-the-business-research-company.aspx
The Business Research Company is a market research and intelligence firm that excels in company, market, and consumer research. It has over 200 research professionals at its offices in India, the UK and the US, as well a network of trained researchers globally. It has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services and technology.
Call us now for personal assistance with your purchase:
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293